Tower Research Capital LLC (Trc) Aclaris Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 21,909 shares of ACRS stock, worth $44,913. This represents 0.0% of its overall portfolio holdings.

Number of Shares

21,909

Previous 20,066 9.18%

Holding current value

$44,913

Previous $22,000 9.09%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.12 - $1.4 $2,064 - $2,580	1,843 Added 9.18%	21,909 $24,000
Q2 2024 Aug 13, 2024	BUY	$1.01 - $1.36 $14,946 - $20,126	14,799 Added 280.98%	20,066 $22,000
Q1 2024 May 15, 2024	SELL	$0.92 - $1.44 $4,118 - $6,446	-4,477 Reduced 45.95%	5,267 $6,000
Q4 2023 Feb 13, 2024	BUY	$0.64 - $6.49 $3,507 - $35,565	5,480 Added 128.52%	9,744 $10,000
Q3 2023 Nov 14, 2023	BUY	$6.56 - $10.95 $20,047 - $33,463	3,056 Added 252.98%	4,264 $29,000
Q2 2023 Aug 14, 2023	SELL	$7.89 - $10.64 $6,864 - $9,256	-870 Reduced 41.87%	1,208 $12,000
Q1 2023 May 09, 2023	BUY	$7.07 - $17.95 $10,166 - $25,812	1,438 Added 224.69%	2,078 $17,000
Q4 2022 Feb 10, 2023	SELL	$14.33 - $18.37 $104,480 - $133,935	-7,291 Reduced 91.93%	640 $10,000
Q3 2022 Nov 10, 2022	SELL	$13.07 - $18.22 $68,865 - $96,001	-5,269 Reduced 39.92%	7,931 $125,000
Q2 2022 Aug 15, 2022	BUY	$10.16 - $17.08 $120,904 - $203,251	11,900 Added 915.38%	13,200 $184,000
Q1 2022 May 12, 2022	SELL	$9.74 - $17.92 $1,470 - $2,705	-151 Reduced 10.41%	1,300 $22,000
Q4 2021 Feb 14, 2022	SELL	$12.27 - $18.49 $64,037 - $96,499	-5,219 Reduced 78.25%	1,451 $22,000
Q3 2021 Nov 15, 2021	SELL	$13.38 - $18.8 $23,910 - $33,595	-1,787 Reduced 21.13%	6,670 $120,000
Q2 2021 Aug 16, 2021	BUY	$17.08 - $29.6 $132,643 - $229,873	7,766 Added 1123.88%	8,457 $149,000
Q1 2021 May 17, 2021	BUY	$5.86 - $27.73 $2,449 - $11,591	418 Added 153.11%	691 $17,000
Q4 2020 Feb 16, 2021	BUY	$2.65 - $7.61 $723 - $2,077	273 New	273 $2,000
Q1 2020 May 15, 2020	SELL	$0.75 - $2.18 $163 - $475	-218 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$1.02 - $1.97 $5,667 - $10,945	-5,556 Reduced 96.22%	218 $0
Q3 2019 Nov 05, 2019	BUY	$0.79 - $2.47 $4,561 - $14,261	5,774 New	5,774 $7,000
Q2 2019 Aug 13, 2019	SELL	$2.13 - $7.06 $2,014 - $6,678	-946 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$5.63 - $7.84 $5,325 - $7,416	946 New	946 $6,000
Q4 2018 Feb 14, 2019	SELL	$6.3 - $15.4 $2,923 - $7,145	-464 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$14.38 - $20.89 $6,672 - $9,692	464 New	464 $7,000
Q1 2018 May 15, 2018	SELL	$17.08 - $25.64 $802 - $1,205	-47 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$21.47 - $27.8 $429 - $556	20 Added 74.07%	47 $1,000
Q3 2017 Nov 14, 2017	BUY	$23.02 - $28.8 $621 - $777	27	27 $1,000

Others Institutions Holding ACRS

# of Institutions

Shares Held

50.7M

Call Options Held

30.6K

Put Options Held

View Full List

About Aclaris Therapeutics, Inc.

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $137M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

More about ACRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Aclaris Therapeutics, Inc. Transaction History